دورية أكاديمية
Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.
| العنوان: | Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective. |
|---|---|
| المؤلفون: | Austin CP; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, Maryland, USA., Cutillo CM; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, Maryland, USA., Lau LPL; IRDiRC Scientific Secretariat, Inserm-US14, Rare Diseases Platform, Paris, France., Jonker AH; IRDiRC Scientific Secretariat, Inserm-US14, Rare Diseases Platform, Paris, France., Rath A; IRDiRC Scientific Secretariat, Inserm-US14, Rare Diseases Platform, Paris, France.; Orphanet, Inserm-US14, Rare Diseases Platform, Paris, France., Julkowska D; Agence Nationale de la Recherche (ANR), Paris, France., Thomson D; Shire, Lexington, Massachusetts, USA, (until April 2017)., Terry SF; Genetic Alliance, Washington DC, USA., de Montleau B; EURORDIS-Rare Diseases Europe, Paris, France., Ardigò D; Corporate Drug Development, Chiesi Farmaceutici S.p.A., Italy., Hivert V; EURORDIS-Rare Diseases Europe, Paris, France., Boycott KM; Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada., Baynam G; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.; Western Australian Register of Developmental Anomalies, Perth, Australia., Kaufmann P; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, Maryland, USA., Taruscio D; National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy., Lochmüller H; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK., Suematsu M; Japan Agency for Medical Research and Development (AMED), Tokyo, Japan., Incerti C; Sanofi Genzyme, Cambridge, Massachusetts, USA., Draghia-Akli R; Directorate General for Research and Innovation (DG RTD), European Commission, Brussels, Belgium, (until April 2017).; Merck & Co. Inc., Upper Gwynedd, Pennsylvania, USA, (from June 2017)., Norstedt I; Directorate General for Research and Innovation (DG RTD), European Commission, Brussels, Belgium, (until April 2017)., Wang L; National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), Bethesda, Maryland, USA., Dawkins HJS; Office of Population Health Genomics, Public Health Division, Department of Health, Government of Western Australia, Perth, Australia. |
| مؤلفون مشاركون: | International Rare Diseases Research Consortium (IRDiRC) |
| المصدر: | Clinical and translational science [Clin Transl Sci] 2018 Jan; Vol. 11 (1), pp. 21-27. Date of Electronic Publication: 2017 Oct 23. |
| نوع المنشور: | Historical Article; Journal Article; Research Support, Non-U.S. Gov't; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Malden, MA : WileyBlackwell Pub., 2008- |
| مواضيع طبية MeSH: | International Cooperation* , Intersectoral Collaboration*, Patient Participation/*trends , Rare Diseases/*diagnosis , Translational Research, Biomedical/*trends, Access to Information ; Goals ; Health Services Accessibility/organization & administration ; Health Services Accessibility/trends ; History, 21st Century ; Humans ; Information Dissemination ; Prevalence ; Rare Diseases/epidemiology ; Rare Diseases/etiology ; Rare Diseases/therapy ; Registries ; Translational Research, Biomedical/economics ; Translational Research, Biomedical/history ; Translational Research, Biomedical/organization & administration |
| References: | Nat Rev Drug Discov. 2010 Dec;9(12):921-9. (PMID: 21060315) Nature. 2011 Apr 7;472(7341):17. (PMID: 21475168) Med J Aust. 2012 Mar 19;196(5):313. (PMID: 22432664) Nat Rev Drug Discov. 2012 Mar 30;11(4):267-8. (PMID: 22460117) Nucleic Acids Res. 2013 Jan;41(Database issue):D925-35. (PMID: 23193275) Genet Med. 2014 Feb;16(2):176-82. (PMID: 23928913) J Gen Intern Med. 2014 Aug;29 Suppl 3:S739-44. (PMID: 25029976) J Gen Intern Med. 2014 Aug;29 Suppl 3:S780-7. (PMID: 25029978) Nucleic Acids Res. 2015 Jan;43(Database issue):D789-98. (PMID: 25428349) Hum Mutat. 2015 Oct;36(10):915-21. (PMID: 26295439) Mol Genet Metab. 2015 Dec;116(4):223-5. (PMID: 26596705) Sci Data. 2016 Apr 12;3:160023. (PMID: 27070114) Nat Rev Drug Discov. 2016 Jun 1;15(6):376. (PMID: 27245390) Nat Rev Drug Discov. 2016 Jun 1;15(6):440-1. (PMID: 27245396) Health Aff (Millwood). 2016 Aug 1;35(8):1367-73. (PMID: 27503959) N Engl J Med. 2016 Aug 18;375(7):655-65. (PMID: 27532831) Nucleic Acids Res. 2017 Jan 4;45(D1):D865-D876. (PMID: 27899602) Gene Ther. 2017 Sep;24(9):562-571. (PMID: 28440796) Am J Hum Genet. 2017 May 4;100(5):695-705. (PMID: 28475856) Eur J Hum Genet. 2017 Sep;25(9):1025-1028. (PMID: 28794428) Clin Transl Sci. 2018 Jan;11(1):11-20. (PMID: 28796411) |
| تواريخ الأحداث: | Date Created: 20170811 Date Completed: 20190503 Latest Revision: 20211204 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC5759721 |
| DOI: | 10.1111/cts.12500 |
| PMID: | 28796445 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1752-8062 |
|---|---|
| DOI: | 10.1111/cts.12500 |